

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.91847069 |
| 2 | nuclear pore organization (GO:0006999) | 6.85927922 |
| 3 | pore complex assembly (GO:0046931) | 5.43334697 |
| 4 | mitotic sister chromatid cohesion (GO:0007064) | 4.90521523 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 4.81981061 |
| 6 | DNA topological change (GO:0006265) | 4.46023876 |
| 7 | negative regulation of DNA repair (GO:0045738) | 4.28425660 |
| 8 | regulation of RNA export from nucleus (GO:0046831) | 4.20376692 |
| 9 | growth hormone receptor signaling pathway (GO:0060396) | 4.10690933 |
| 10 | negative regulation of B cell proliferation (GO:0030889) | 4.02728781 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 3.99489057 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.94567852 |
| 13 | V(D)J recombination (GO:0033151) | 3.90212598 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.82721549 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 3.82721549 |
| 16 | glyoxylate metabolic process (GO:0046487) | 3.79757498 |
| 17 | sister chromatid segregation (GO:0000819) | 3.79342815 |
| 18 | mitotic G2/M transition checkpoint (GO:0044818) | 3.76404267 |
| 19 | regulation of centriole replication (GO:0046599) | 3.75892574 |
| 20 | mitotic chromosome condensation (GO:0007076) | 3.70501307 |
| 21 | ribosome assembly (GO:0042255) | 3.67868426 |
| 22 | CENP-A containing nucleosome assembly (GO:0034080) | 3.67560503 |
| 23 | regulation of sister chromatid cohesion (GO:0007063) | 3.67336113 |
| 24 | mitotic G2 DNA damage checkpoint (GO:0007095) | 3.67330383 |
| 25 | protein localization to chromosome, centromeric region (GO:0071459) | 3.66769798 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 3.65638349 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 3.64319899 |
| 28 | chromatin remodeling at centromere (GO:0031055) | 3.61660512 |
| 29 | regulation of histone H3-K9 methylation (GO:0051570) | 3.56955998 |
| 30 | cellular glucuronidation (GO:0052695) | 3.50744332 |
| 31 | embryonic process involved in female pregnancy (GO:0060136) | 3.46662368 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.46450188 |
| 33 | urea metabolic process (GO:0019627) | 3.45657847 |
| 34 | urea cycle (GO:0000050) | 3.45657847 |
| 35 | protein carboxylation (GO:0018214) | 3.44645127 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44645127 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.43982378 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.43982378 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.43982378 |
| 40 | DNA duplex unwinding (GO:0032508) | 3.43032200 |
| 41 | cellular response to growth hormone stimulus (GO:0071378) | 3.42948662 |
| 42 | mitotic spindle checkpoint (GO:0071174) | 3.41534958 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38379189 |
| 44 | L-phenylalanine metabolic process (GO:0006558) | 3.38379189 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.37680834 |
| 46 | mitotic nuclear envelope disassembly (GO:0007077) | 3.37030508 |
| 47 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.36353822 |
| 48 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.36353822 |
| 49 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.36353822 |
| 50 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.36353822 |
| 51 | negative regulation of sister chromatid segregation (GO:0033046) | 3.36353822 |
| 52 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.36325525 |
| 53 | mitotic metaphase plate congression (GO:0007080) | 3.35816101 |
| 54 | protein localization to kinetochore (GO:0034501) | 3.35721329 |
| 55 | non-recombinational repair (GO:0000726) | 3.34064814 |
| 56 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.34064814 |
| 57 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.33614606 |
| 58 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.33614606 |
| 59 | DNA geometric change (GO:0032392) | 3.33561452 |
| 60 | negative regulation of chromosome segregation (GO:0051985) | 3.32176399 |
| 61 | regulation of fibrinolysis (GO:0051917) | 3.29312560 |
| 62 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.29090492 |
| 63 | bile acid biosynthetic process (GO:0006699) | 3.28204383 |
| 64 | mitotic spindle assembly checkpoint (GO:0007094) | 3.25775827 |
| 65 | complement activation, alternative pathway (GO:0006957) | 3.24661582 |
| 66 | regulation of sister chromatid segregation (GO:0033045) | 3.23762620 |
| 67 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.23762620 |
| 68 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.23762620 |
| 69 | spindle checkpoint (GO:0031577) | 3.23600808 |
| 70 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.23022203 |
| 71 | regulation of translational fidelity (GO:0006450) | 3.22273028 |
| 72 | nuclear envelope disassembly (GO:0051081) | 3.21640495 |
| 73 | membrane disassembly (GO:0030397) | 3.21640495 |
| 74 | uronic acid metabolic process (GO:0006063) | 3.20866748 |
| 75 | glucuronate metabolic process (GO:0019585) | 3.20866748 |
| 76 | spindle assembly checkpoint (GO:0071173) | 3.19279254 |
| 77 | kinetochore organization (GO:0051383) | 3.18140943 |
| 78 | kynurenine metabolic process (GO:0070189) | 3.17420515 |
| 79 | pre-miRNA processing (GO:0031054) | 3.16651336 |
| 80 | regulation of chromosome segregation (GO:0051983) | 3.15486021 |
| 81 | mitotic sister chromatid segregation (GO:0000070) | 3.11531015 |
| 82 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.09385780 |
| 83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09265427 |
| 84 | regulation of centrosome cycle (GO:0046605) | 3.07905290 |
| 85 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07415270 |
| 86 | IMP metabolic process (GO:0046040) | 3.07332931 |
| 87 | phospholipid efflux (GO:0033700) | 3.05742523 |
| 88 | nitrogen cycle metabolic process (GO:0071941) | 3.04215670 |
| 89 | regulation of centrosome duplication (GO:0010824) | 3.03147054 |
| 90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03096324 |
| 91 | keratinization (GO:0031424) | 3.02698834 |
| 92 | metaphase plate congression (GO:0051310) | 3.02545395 |
| 93 | regulation of protein activation cascade (GO:2000257) | 3.02445590 |
| 94 | histone exchange (GO:0043486) | 3.01946286 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.01021469 |
| 96 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.00689061 |
| 97 | DNA replication-independent nucleosome organization (GO:0034724) | 3.00689061 |
| 98 | regulation of cholesterol esterification (GO:0010872) | 3.00634118 |
| 99 | midgut development (GO:0007494) | 2.99388434 |
| 100 | cell adhesion mediated by integrin (GO:0033627) | 2.97303705 |
| 101 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.96170543 |
| 102 | somatic cell DNA recombination (GO:0016444) | 2.95371285 |
| 103 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.95371285 |
| 104 | DNA replication initiation (GO:0006270) | 2.94467908 |
| 105 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.93990082 |
| 106 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.90042392 |
| 107 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.88580921 |
| 108 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88442103 |
| 109 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.87865903 |
| 110 | DNA conformation change (GO:0071103) | 2.87676275 |
| 111 | establishment of integrated proviral latency (GO:0075713) | 2.87436983 |
| 112 | regulation of interferon-alpha production (GO:0032647) | 2.82662019 |
| 113 | response to inactivity (GO:0014854) | 2.81608375 |
| 114 | cellular protein complex localization (GO:0034629) | 2.81387314 |
| 115 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.81038723 |
| 116 | regulation of complement activation (GO:0030449) | 2.80804037 |
| 117 | histone-serine phosphorylation (GO:0035404) | 2.80492066 |
| 118 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.80457139 |
| 119 | IMP biosynthetic process (GO:0006188) | 2.79704353 |
| 120 | mitotic DNA integrity checkpoint (GO:0044774) | 2.79622736 |
| 121 | establishment of chromosome localization (GO:0051303) | 2.79481455 |
| 122 | DNA replication checkpoint (GO:0000076) | 2.79295761 |
| 123 | COPII vesicle coating (GO:0048208) | 2.79273758 |
| 124 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.78367320 |
| 125 | positive regulation of chromosome segregation (GO:0051984) | 2.78236398 |
| 126 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.78061153 |
| 127 | interkinetic nuclear migration (GO:0022027) | 2.75489324 |
| 128 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.73652435 |
| 129 | reverse cholesterol transport (GO:0043691) | 2.70135199 |
| 130 | response to growth hormone (GO:0060416) | 2.69488196 |
| 131 | homocysteine metabolic process (GO:0050667) | 2.69334871 |
| 132 | ATP-dependent chromatin remodeling (GO:0043044) | 2.68765397 |
| 133 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.67226087 |
| 134 | response to UV-C (GO:0010225) | 2.66885659 |
| 135 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.66460686 |
| 136 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.66460686 |
| 137 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.66460686 |
| 138 | valine metabolic process (GO:0006573) | 2.66177211 |
| 139 | positive regulation of lipid catabolic process (GO:0050996) | 2.65948550 |
| 140 | T-helper cell differentiation (GO:0042093) | 2.65770196 |
| 141 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.65770196 |
| 142 | regulation of triglyceride catabolic process (GO:0010896) | 2.65188853 |
| 143 | cholesterol efflux (GO:0033344) | 2.64243426 |
| 144 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.64219009 |
| 145 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.63555619 |
| 146 | replicative senescence (GO:0090399) | 2.62833303 |
| 147 | regulation of helicase activity (GO:0051095) | 2.62804821 |
| 148 | prenylation (GO:0097354) | 2.62707765 |
| 149 | protein prenylation (GO:0018342) | 2.62707765 |
| 150 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.62528938 |
| 151 | negative regulation of B cell activation (GO:0050869) | 2.61552414 |
| 152 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.61436382 |
| 153 | definitive hemopoiesis (GO:0060216) | 2.61281415 |
| 154 | positive regulation of histone methylation (GO:0031062) | 2.59082849 |
| 155 | cellular response to ethanol (GO:0071361) | 2.58743644 |
| 156 | bile acid metabolic process (GO:0008206) | 2.58641268 |
| 157 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.58449086 |
| 158 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58169231 |
| 159 | tyrosine metabolic process (GO:0006570) | 2.56621989 |
| 160 | indolalkylamine metabolic process (GO:0006586) | 2.56525166 |
| 161 | negative regulation of mitosis (GO:0045839) | 2.53974077 |
| 162 | diterpenoid biosynthetic process (GO:0016102) | 2.53339997 |
| 163 | low-density lipoprotein particle remodeling (GO:0034374) | 2.53012245 |
| 164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52334566 |
| 165 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.51995503 |
| 166 | protein-lipid complex remodeling (GO:0034368) | 2.50148474 |
| 167 | macromolecular complex remodeling (GO:0034367) | 2.50148474 |
| 168 | plasma lipoprotein particle remodeling (GO:0034369) | 2.50148474 |
| 169 | positive regulation of fatty acid oxidation (GO:0046321) | 2.48649071 |
| 170 | lysine metabolic process (GO:0006553) | 2.43727333 |
| 171 | lysine catabolic process (GO:0006554) | 2.43727333 |
| 172 | negative regulation of lipid storage (GO:0010888) | 2.41316771 |
| 173 | regulation of immunoglobulin secretion (GO:0051023) | 2.40178974 |
| 174 | positive regulation of blood coagulation (GO:0030194) | 2.39116531 |
| 175 | positive regulation of hemostasis (GO:1900048) | 2.39116531 |
| 176 | negative regulation of fatty acid transport (GO:2000192) | 2.35706307 |
| 177 | regulation of regulatory T cell differentiation (GO:0045589) | 2.35385928 |
| 178 | positive regulation of T cell chemotaxis (GO:0010820) | 2.35007259 |
| 179 | regulation of T cell chemotaxis (GO:0010819) | 2.35007259 |
| 180 | plasma lipoprotein particle clearance (GO:0034381) | 2.34832967 |
| 181 | lipoprotein metabolic process (GO:0042157) | 2.34119364 |
| 182 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.33974081 |
| 183 | NIK/NF-kappaB signaling (GO:0038061) | 2.33864782 |
| 184 | aromatic amino acid family metabolic process (GO:0009072) | 2.33532293 |
| 185 | negative thymic T cell selection (GO:0045060) | 2.32167132 |
| 186 | fibrinolysis (GO:0042730) | 2.30924242 |
| 187 | epoxygenase P450 pathway (GO:0019373) | 2.30119789 |
| 188 | aldehyde catabolic process (GO:0046185) | 2.28219218 |
| 189 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.25667967 |
| 190 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.25472397 |
| 191 | cytolysis (GO:0019835) | 2.25292958 |
| 192 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.25082644 |
| 193 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.24654301 |
| 194 | neural tube formation (GO:0001841) | 2.21493398 |
| 195 | positive regulation of coagulation (GO:0050820) | 2.21170899 |
| 196 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.20973549 |
| 197 | acylglycerol homeostasis (GO:0055090) | 2.20043242 |
| 198 | triglyceride homeostasis (GO:0070328) | 2.20043242 |
| 199 | substrate-dependent cell migration (GO:0006929) | 2.18392454 |
| 200 | arginine metabolic process (GO:0006525) | 2.18239934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.42174814 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.58051501 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.49423027 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.69114333 |
| 5 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.25327825 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.21800554 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.06758745 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00332537 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.93413264 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.86803989 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.78851539 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75600914 |
| 13 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.55132880 |
| 14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.54802940 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.53519732 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52766627 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.45933066 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37293718 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28301421 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.26380209 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22308724 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20372957 |
| 23 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.14800455 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.12323026 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.07388171 |
| 26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.05895311 |
| 27 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.04980790 |
| 28 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.04980790 |
| 29 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.02512664 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02386332 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94032337 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.93290068 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86823925 |
| 34 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.84939583 |
| 35 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81872015 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81346901 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.81306740 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81269427 |
| 39 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80194154 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74771140 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.74464596 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.73027955 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71830128 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67403037 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67215784 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.66101760 |
| 47 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.63023836 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61995271 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60871776 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59907945 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.57801777 |
| 52 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55766143 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54882675 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.51411846 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51332130 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50695660 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50617394 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50255106 |
| 59 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49993258 |
| 60 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.47921461 |
| 61 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46306355 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46076848 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45355784 |
| 64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44846169 |
| 65 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43388340 |
| 66 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42617516 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42359030 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41470040 |
| 69 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.40083869 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.40040057 |
| 71 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.38231276 |
| 72 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.36505387 |
| 73 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35446253 |
| 74 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.35381384 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33285892 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32811705 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31117068 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30584396 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29956315 |
| 80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.27453922 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26536999 |
| 82 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.25719738 |
| 83 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.25120549 |
| 84 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23316079 |
| 85 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.22175383 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21333447 |
| 87 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.21301927 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21082503 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17513286 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16987194 |
| 91 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15939786 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15802122 |
| 93 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.15441138 |
| 94 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15119727 |
| 95 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13895303 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12514846 |
| 97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12474650 |
| 98 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11917903 |
| 99 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11855401 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11789300 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11789300 |
| 102 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.11057482 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.11057482 |
| 104 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.11057482 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11010718 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10863874 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10831936 |
| 108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08822461 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08320438 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07197012 |
| 111 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06573481 |
| 112 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05287231 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03069110 |
| 114 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02880262 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02281253 |
| 116 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00735815 |
| 117 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00548377 |
| 118 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00320330 |
| 119 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.99933692 |
| 120 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99452594 |
| 121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97729326 |
| 122 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97508128 |
| 123 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96061632 |
| 124 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95922626 |
| 125 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.95133901 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94286056 |
| 127 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93671422 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93663078 |
| 129 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93436715 |
| 130 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93381624 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93113149 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93006663 |
| 133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92646747 |
| 134 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92645772 |
| 135 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.92602951 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92132922 |
| 137 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.91097351 |
| 138 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.90961825 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90694336 |
| 140 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.89304933 |
| 141 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89204887 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89182952 |
| 143 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89092342 |
| 144 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88809417 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87886175 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87864283 |
| 147 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87521754 |
| 148 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.86474093 |
| 149 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.85881427 |
| 150 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85573300 |
| 151 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85075467 |
| 152 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84734009 |
| 153 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84625421 |
| 154 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.84606245 |
| 155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83720183 |
| 156 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83478575 |
| 157 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83228842 |
| 158 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83122107 |
| 159 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82830217 |
| 160 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.82736606 |
| 161 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.82583522 |
| 162 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82308618 |
| 163 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82291162 |
| 164 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82170911 |
| 165 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.81935292 |
| 166 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.81528696 |
| 167 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81446211 |
| 168 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80790016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.96381748 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.89701014 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.76524268 |
| 4 | MP0005360_urolithiasis | 3.72803043 |
| 5 | MP0003941_abnormal_skin_development | 3.50321936 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.48694027 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.36036750 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.20804125 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.16548999 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.13747290 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.98138072 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.98067573 |
| 13 | MP0005365_abnormal_bile_salt | 2.91974533 |
| 14 | MP0003252_abnormal_bile_duct | 2.87570044 |
| 15 | MP0003890_abnormal_embryonic-extraembry | 2.79491475 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.64950427 |
| 17 | MP0003303_peritoneal_inflammation | 2.61972012 |
| 18 | MP0002796_impaired_skin_barrier | 2.61550036 |
| 19 | MP0001348_abnormal_lacrimal_gland | 2.53482954 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.49004213 |
| 21 | MP0003077_abnormal_cell_cycle | 2.25902060 |
| 22 | MP0009053_abnormal_anal_canal | 2.20368755 |
| 23 | MP0002009_preneoplasia | 2.19171180 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.18386807 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 2.12936726 |
| 26 | MP0010368_abnormal_lymphatic_system | 2.11084194 |
| 27 | MP0001879_abnormal_lymphatic_vessel | 2.07159058 |
| 28 | MP0003693_abnormal_embryo_hatching | 2.06098510 |
| 29 | MP0004510_myositis | 2.05726679 |
| 30 | MP0005083_abnormal_biliary_tract | 1.94594649 |
| 31 | MP0005451_abnormal_body_composition | 1.91612382 |
| 32 | MP0001661_extended_life_span | 1.90531996 |
| 33 | MP0008058_abnormal_DNA_repair | 1.87050764 |
| 34 | MP0001730_embryonic_growth_arrest | 1.86652040 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85237287 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.84210651 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.79496599 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.79258243 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.77539412 |
| 40 | MP0005503_abnormal_tendon_morphology | 1.68972320 |
| 41 | MP0005671_abnormal_response_to | 1.68756487 |
| 42 | MP0005408_hypopigmentation | 1.66848314 |
| 43 | MP0003984_embryonic_growth_retardation | 1.63411410 |
| 44 | MP0001672_abnormal_embryogenesis/_devel | 1.62835851 |
| 45 | MP0005380_embryogenesis_phenotype | 1.62835851 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.62671963 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.62069841 |
| 48 | MP0005275_abnormal_skin_tensile | 1.60913438 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.60894816 |
| 50 | MP0001790_abnormal_immune_system | 1.59270873 |
| 51 | MP0005387_immune_system_phenotype | 1.59270873 |
| 52 | MP0002006_tumorigenesis | 1.58780521 |
| 53 | MP0009672_abnormal_birth_weight | 1.57516434 |
| 54 | MP0001873_stomach_inflammation | 1.57203317 |
| 55 | MP0010307_abnormal_tumor_latency | 1.55016551 |
| 56 | MP0001697_abnormal_embryo_size | 1.51572265 |
| 57 | MP0005501_abnormal_skin_physiology | 1.49376711 |
| 58 | MP0003195_calcinosis | 1.48274166 |
| 59 | MP0002086_abnormal_extraembryonic_tissu | 1.47561404 |
| 60 | MP0010678_abnormal_skin_adnexa | 1.45987295 |
| 61 | MP0003279_aneurysm | 1.45450211 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.45258992 |
| 63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44900534 |
| 64 | MP0000350_abnormal_cell_proliferation | 1.43154107 |
| 65 | MP0002084_abnormal_developmental_patter | 1.38597089 |
| 66 | MP0005248_abnormal_Harderian_gland | 1.36503152 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.36059108 |
| 68 | MP0005332_abnormal_amino_acid | 1.35671937 |
| 69 | MP0003718_maternal_effect | 1.31406661 |
| 70 | MP0001853_heart_inflammation | 1.30898203 |
| 71 | MP0009384_cardiac_valve_regurgitation | 1.29911944 |
| 72 | MP0009697_abnormal_copulation | 1.27484283 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.25768408 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 1.25017692 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.21286277 |
| 76 | MP0001915_intracranial_hemorrhage | 1.20705584 |
| 77 | MP0001177_atelectasis | 1.20673330 |
| 78 | MP0004197_abnormal_fetal_growth/weight/ | 1.20474787 |
| 79 | MP0006082_CNS_inflammation | 1.20096892 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.17850410 |
| 81 | MP0000685_abnormal_immune_system | 1.17547708 |
| 82 | MP0000428_abnormal_craniofacial_morphol | 1.16846160 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.16546024 |
| 84 | MP0002697_abnormal_eye_size | 1.16434941 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 1.14818893 |
| 86 | MP0000516_abnormal_urinary_system | 1.14818893 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 1.14571289 |
| 88 | MP0002080_prenatal_lethality | 1.14013431 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 1.13974442 |
| 90 | MP0001958_emphysema | 1.13888920 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 1.13075202 |
| 92 | MP0009703_decreased_birth_body | 1.11446093 |
| 93 | MP0004036_abnormal_muscle_relaxation | 1.09783405 |
| 94 | MP0010630_abnormal_cardiac_muscle | 1.09016749 |
| 95 | MP0001346_abnormal_lacrimal_gland | 1.08778136 |
| 96 | MP0002254_reproductive_system_inflammat | 1.08712883 |
| 97 | MP0009785_altered_susceptibility_to | 1.08299955 |
| 98 | MP0009764_decreased_sensitivity_to | 1.07585770 |
| 99 | MP0001216_abnormal_epidermal_layer | 1.04985979 |
| 100 | MP0004215_abnormal_myocardial_fiber | 1.04018651 |
| 101 | MP0005310_abnormal_salivary_gland | 1.03526505 |
| 102 | MP0003091_abnormal_cell_migration | 1.03464353 |
| 103 | MP0001293_anophthalmia | 1.03063025 |
| 104 | MP0002085_abnormal_embryonic_tissue | 1.02281964 |
| 105 | MP0004808_abnormal_hematopoietic_stem | 1.02172160 |
| 106 | MP0005076_abnormal_cell_differentiation | 1.01957943 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 1.00879753 |
| 108 | MP0000767_abnormal_smooth_muscle | 1.00589235 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.99681574 |
| 110 | MP0000383_abnormal_hair_follicle | 0.99122240 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.99014811 |
| 112 | MP0002269_muscular_atrophy | 0.98973750 |
| 113 | MP0002092_abnormal_eye_morphology | 0.97715529 |
| 114 | MP0004147_increased_porphyrin_level | 0.96646254 |
| 115 | MP0003385_abnormal_body_wall | 0.96463334 |
| 116 | MP0004084_abnormal_cardiac_muscle | 0.96035523 |
| 117 | MP0003436_decreased_susceptibility_to | 0.95516311 |
| 118 | MP0004233_abnormal_muscle_weight | 0.95312673 |
| 119 | MP0004272_abnormal_basement_membrane | 0.93927328 |
| 120 | MP0003786_premature_aging | 0.93538744 |
| 121 | MP0005023_abnormal_wound_healing | 0.92888689 |
| 122 | MP0002928_abnormal_bile_duct | 0.92857029 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.92787771 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.92395737 |
| 125 | MP0003942_abnormal_urinary_system | 0.92191533 |
| 126 | MP0006138_congestive_heart_failure | 0.91735242 |
| 127 | MP0003186_abnormal_redox_activity | 0.91415482 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.90628769 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.90620161 |
| 130 | MP0004883_abnormal_blood_vessel | 0.90518317 |
| 131 | MP0001800_abnormal_humoral_immune | 0.89301284 |
| 132 | MP0002128_abnormal_blood_circulation | 0.88221054 |
| 133 | MP0001666_abnormal_nutrient_absorption | 0.88150871 |
| 134 | MP0003868_abnormal_feces_composition | 0.87641672 |
| 135 | MP0005171_absent_coat_pigmentation | 0.86269034 |
| 136 | MP0001191_abnormal_skin_condition | 0.85582884 |
| 137 | MP0000609_abnormal_liver_physiology | 0.85527612 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.85108128 |
| 139 | MP0003950_abnormal_plasma_membrane | 0.83474494 |
| 140 | MP0002118_abnormal_lipid_homeostasis | 0.82428563 |
| 141 | MP0002933_joint_inflammation | 0.82235564 |
| 142 | MP0001286_abnormal_eye_development | 0.80269596 |
| 143 | MP0003935_abnormal_craniofacial_develop | 0.79619788 |
| 144 | MP0005000_abnormal_immune_tolerance | 0.79496839 |
| 145 | MP0003448_altered_tumor_morphology | 0.78909928 |
| 146 | MP0000598_abnormal_liver_morphology | 0.78833706 |
| 147 | MP0006054_spinal_hemorrhage | 0.78645495 |
| 148 | MP0002060_abnormal_skin_morphology | 0.78313965 |
| 149 | MP0000377_abnormal_hair_follicle | 0.77290298 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77239492 |
| 151 | MP0002163_abnormal_gland_morphology | 0.76555323 |
| 152 | MP0004130_abnormal_muscle_cell | 0.76315231 |
| 153 | MP0001544_abnormal_cardiovascular_syste | 0.76152216 |
| 154 | MP0005385_cardiovascular_system_phenoty | 0.76152216 |
| 155 | MP0000579_abnormal_nail_morphology | 0.75250297 |
| 156 | MP0002972_abnormal_cardiac_muscle | 0.75052060 |
| 157 | MP0000313_abnormal_cell_death | 0.74812343 |
| 158 | MP0000249_abnormal_blood_vessel | 0.74552499 |
| 159 | MP0001542_abnormal_bone_strength | 0.74234097 |
| 160 | MP0009763_increased_sensitivity_to | 0.73836897 |
| 161 | MP0005197_abnormal_uvea_morphology | 0.73361657 |
| 162 | MP0001764_abnormal_homeostasis | 0.73232683 |
| 163 | MP0004087_abnormal_muscle_fiber | 0.73192317 |
| 164 | MP0000647_abnormal_sebaceous_gland | 0.71998294 |
| 165 | MP0000432_abnormal_head_morphology | 0.71197225 |
| 166 | MP0002452_abnormal_antigen_presenting | 0.71193264 |
| 167 | MP0001881_abnormal_mammary_gland | 0.70644281 |
| 168 | MP0000566_synostosis | 0.70140281 |
| 169 | MP0001188_hyperpigmentation | 0.69995796 |
| 170 | MP0002095_abnormal_skin_pigmentation | 0.68613757 |
| 171 | MP0005330_cardiomyopathy | 0.68539860 |
| 172 | MP0001784_abnormal_fluid_regulation | 0.65109633 |
| 173 | MP0001299_abnormal_eye_distance/ | 0.63742522 |
| 174 | MP0003646_muscle_fatigue | 0.62974758 |
| 175 | MP0005621_abnormal_cell_physiology | 0.61444226 |
| 176 | MP0002019_abnormal_tumor_incidence | 0.61308702 |
| 177 | MP0005666_abnormal_adipose_tissue | 0.60824920 |
| 178 | MP0002233_abnormal_nose_morphology | 0.60132514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 4.82645039 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.82645039 |
| 3 | Orchitis (HP:0100796) | 4.23925007 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.21892301 |
| 5 | Acanthocytosis (HP:0001927) | 3.75827029 |
| 6 | Chromsome breakage (HP:0040012) | 3.71731961 |
| 7 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.71333948 |
| 8 | Epidermoid cyst (HP:0200040) | 3.61535612 |
| 9 | Arterial thrombosis (HP:0004420) | 3.61161381 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 3.54468076 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.53477965 |
| 12 | Embryonal renal neoplasm (HP:0011794) | 3.51464849 |
| 13 | B lymphocytopenia (HP:0010976) | 3.48835805 |
| 14 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.48454385 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 3.46595015 |
| 16 | Pulmonary embolism (HP:0002204) | 3.40989460 |
| 17 | Aortic aneurysm (HP:0004942) | 3.34486655 |
| 18 | Myocardial infarction (HP:0001658) | 3.29274179 |
| 19 | Thrombophlebitis (HP:0004418) | 3.23267276 |
| 20 | Asymmetry of the thorax (HP:0001555) | 3.21386638 |
| 21 | Hepatocellular carcinoma (HP:0001402) | 3.20020452 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.16114722 |
| 23 | Syringomyelia (HP:0003396) | 3.14575538 |
| 24 | Spinal cord lesions (HP:0100561) | 3.14575538 |
| 25 | Myositis (HP:0100614) | 3.10466192 |
| 26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.07504870 |
| 27 | Subaortic stenosis (HP:0001682) | 3.07504870 |
| 28 | Keratoconjunctivitis (HP:0001096) | 3.03814264 |
| 29 | Hepatoblastoma (HP:0002884) | 3.02783313 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.01773485 |
| 31 | Papillary thyroid carcinoma (HP:0002895) | 3.00310827 |
| 32 | Hypoplasia of the thymus (HP:0000778) | 3.00003161 |
| 33 | Subacute progressive viral hepatitis (HP:0006572) | 2.97417122 |
| 34 | Biliary tract neoplasm (HP:0100574) | 2.92649497 |
| 35 | Erythroderma (HP:0001019) | 2.92539640 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.91432194 |
| 37 | Complement deficiency (HP:0004431) | 2.89733468 |
| 38 | Spontaneous abortion (HP:0005268) | 2.86956624 |
| 39 | Neoplasm of the small intestine (HP:0100833) | 2.85907712 |
| 40 | Acute myeloid leukemia (HP:0004808) | 2.84976549 |
| 41 | Gangrene (HP:0100758) | 2.83906021 |
| 42 | Xanthomatosis (HP:0000991) | 2.83787625 |
| 43 | Abnormality of B cell number (HP:0010975) | 2.83727403 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82267823 |
| 45 | Acute hepatic failure (HP:0006554) | 2.81175512 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.80335981 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.77629404 |
| 48 | Mitral stenosis (HP:0001718) | 2.75292097 |
| 49 | Vasculitis (HP:0002633) | 2.75008601 |
| 50 | Ankyloglossia (HP:0010296) | 2.73730461 |
| 51 | Abnormality of chromosome stability (HP:0003220) | 2.68839915 |
| 52 | Gastrointestinal carcinoma (HP:0002672) | 2.65732363 |
| 53 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.65732363 |
| 54 | Progressive external ophthalmoplegia (HP:0000590) | 2.64833943 |
| 55 | Rhabdomyosarcoma (HP:0002859) | 2.63957401 |
| 56 | Peritonitis (HP:0002586) | 2.61461807 |
| 57 | Curly hair (HP:0002212) | 2.58517827 |
| 58 | Combined immunodeficiency (HP:0005387) | 2.57737960 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.52980213 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.50415088 |
| 61 | Selective tooth agenesis (HP:0001592) | 2.46909533 |
| 62 | T lymphocytopenia (HP:0005403) | 2.46667301 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.46547790 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.40961834 |
| 65 | Abnormal lung lobation (HP:0002101) | 2.39716568 |
| 66 | Abnormality of the pericardium (HP:0001697) | 2.39458025 |
| 67 | Joint hemorrhage (HP:0005261) | 2.37854161 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.36578949 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.36150921 |
| 70 | Thyroiditis (HP:0100646) | 2.35723707 |
| 71 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33864659 |
| 72 | Esophageal varix (HP:0002040) | 2.33545071 |
| 73 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.30293206 |
| 74 | Aortic dissection (HP:0002647) | 2.29567950 |
| 75 | Ovarian neoplasm (HP:0100615) | 2.29496300 |
| 76 | Gingival bleeding (HP:0000225) | 2.29027286 |
| 77 | Uterine leiomyosarcoma (HP:0002891) | 2.28133778 |
| 78 | Leiomyosarcoma (HP:0100243) | 2.28133778 |
| 79 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.28080035 |
| 80 | Embryonal neoplasm (HP:0002898) | 2.25426646 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.25133445 |
| 82 | Uterine neoplasm (HP:0010784) | 2.23692768 |
| 83 | Nemaline bodies (HP:0003798) | 2.23637996 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.21549768 |
| 85 | Abnormality of complement system (HP:0005339) | 2.21112013 |
| 86 | Neoplasm of the colon (HP:0100273) | 2.21044201 |
| 87 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.19753816 |
| 88 | Neoplasm of the adrenal gland (HP:0100631) | 2.19174566 |
| 89 | Abnormality of the axillary hair (HP:0100134) | 2.18924168 |
| 90 | Abnormality of secondary sexual hair (HP:0009888) | 2.18924168 |
| 91 | Medulloblastoma (HP:0002885) | 2.18193282 |
| 92 | Glomerulopathy (HP:0100820) | 2.18039045 |
| 93 | Vascular tortuosity (HP:0004948) | 2.17848539 |
| 94 | Hemoptysis (HP:0002105) | 2.16156140 |
| 95 | Alveolar cell carcinoma (HP:0006519) | 2.13444941 |
| 96 | Joint swelling (HP:0001386) | 2.13408934 |
| 97 | Muscle fiber inclusion bodies (HP:0100299) | 2.12056615 |
| 98 | Neoplasm of the adrenal cortex (HP:0100641) | 2.10860403 |
| 99 | Multiple enchondromatosis (HP:0005701) | 2.09453505 |
| 100 | Insidious onset (HP:0003587) | 2.08363987 |
| 101 | Termporal pattern (HP:0011008) | 2.08363987 |
| 102 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.08273376 |
| 103 | Abnormal biliary tract morphology (HP:0012440) | 2.08154959 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.07979725 |
| 105 | Hydroxyprolinuria (HP:0003080) | 2.07979725 |
| 106 | Increased IgM level (HP:0003496) | 2.07321134 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.06597467 |
| 108 | Bladder carcinoma (HP:0002862) | 2.06096478 |
| 109 | Bladder neoplasm (HP:0009725) | 2.06096478 |
| 110 | Abnormality of oral frenula (HP:0000190) | 2.05109094 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.04057301 |
| 112 | Volvulus (HP:0002580) | 2.03678296 |
| 113 | Tetraparesis (HP:0002273) | 2.03666264 |
| 114 | Fat malabsorption (HP:0002630) | 2.03200461 |
| 115 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.02355653 |
| 116 | Hypoalphalipoproteinemia (HP:0003233) | 2.02263689 |
| 117 | Increased nuchal translucency (HP:0010880) | 2.02140502 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 2.02045742 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 2.01705448 |
| 120 | Pancreatitis (HP:0001733) | 2.01473142 |
| 121 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.99063129 |
| 122 | Neoplasm of the rectum (HP:0100743) | 1.98699099 |
| 123 | Missing ribs (HP:0000921) | 1.98459871 |
| 124 | Hypercholesterolemia (HP:0003124) | 1.97782562 |
| 125 | Chest pain (HP:0100749) | 1.97755816 |
| 126 | Abnormality of methionine metabolism (HP:0010901) | 1.97430173 |
| 127 | Chorioretinal atrophy (HP:0000533) | 1.97162332 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.96199006 |
| 129 | Overlapping toe (HP:0001845) | 1.94718793 |
| 130 | Hypoproteinemia (HP:0003075) | 1.94635398 |
| 131 | Abnormality of the preputium (HP:0100587) | 1.94306511 |
| 132 | Cystic hygroma (HP:0000476) | 1.93073992 |
| 133 | Dilatation of the ascending aorta (HP:0005111) | 1.91702809 |
| 134 | Orthostatic hypotension (HP:0001278) | 1.90513602 |
| 135 | Short middle phalanx of the 5th finger (HP:0004220) | 1.89983303 |
| 136 | Abnormality of T cell number (HP:0011839) | 1.88931003 |
| 137 | Abnormality of nail color (HP:0100643) | 1.88555947 |
| 138 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87747942 |
| 139 | Fair hair (HP:0002286) | 1.87388964 |
| 140 | Decreased lacrimation (HP:0000633) | 1.86873191 |
| 141 | Aplasia involving bones of the extremities (HP:0009825) | 1.85594776 |
| 142 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85594776 |
| 143 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85594776 |
| 144 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85342967 |
| 145 | Osteolytic defects of the hand bones (HP:0009699) | 1.85342967 |
| 146 | Abnormal platelet volume (HP:0011876) | 1.85296684 |
| 147 | Sandal gap (HP:0001852) | 1.84903476 |
| 148 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83991381 |
| 149 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83887967 |
| 150 | Palmar hyperkeratosis (HP:0010765) | 1.83875367 |
| 151 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83701840 |
| 152 | Deep philtrum (HP:0002002) | 1.83632403 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.83043632 |
| 154 | Colon cancer (HP:0003003) | 1.82942952 |
| 155 | Alacrima (HP:0000522) | 1.81968085 |
| 156 | Abnormal foot bone ossification (HP:0010675) | 1.81204557 |
| 157 | Abnormality of the salivary glands (HP:0010286) | 1.81057102 |
| 158 | Encephalitis (HP:0002383) | 1.81033114 |
| 159 | 11 pairs of ribs (HP:0000878) | 1.79982424 |
| 160 | Lymphangioma (HP:0100764) | 1.79211869 |
| 161 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.79097320 |
| 162 | Acute lymphatic leukemia (HP:0006721) | 1.77698341 |
| 163 | Enlarged kidneys (HP:0000105) | 1.77680699 |
| 164 | IgM deficiency (HP:0002850) | 1.77478279 |
| 165 | Duodenal stenosis (HP:0100867) | 1.77037196 |
| 166 | Small intestinal stenosis (HP:0012848) | 1.77037196 |
| 167 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.76476800 |
| 168 | Absent eyelashes (HP:0000561) | 1.76249235 |
| 169 | Clitoromegaly (HP:0000057) | 1.76127435 |
| 170 | Long clavicles (HP:0000890) | 1.75937564 |
| 171 | Poikilocytosis (HP:0004447) | 1.75207564 |
| 172 | Hematochezia (HP:0002573) | 1.74643117 |
| 173 | Meckel diverticulum (HP:0002245) | 1.74285342 |
| 174 | Systemic lupus erythematosus (HP:0002725) | 1.73723839 |
| 175 | Abnormality of chromosome segregation (HP:0002916) | 1.72870158 |
| 176 | Cerebral hemorrhage (HP:0001342) | 1.71840501 |
| 177 | Cortical dysplasia (HP:0002539) | 1.71778825 |
| 178 | Abnormality of the nasal septum (HP:0000419) | 1.71434045 |
| 179 | Mesomelia (HP:0003027) | 1.71114903 |
| 180 | Rimmed vacuoles (HP:0003805) | 1.70733601 |
| 181 | Absent eyebrow (HP:0002223) | 1.70082693 |
| 182 | Exercise-induced muscle cramps (HP:0003710) | 1.68583399 |
| 183 | Capillary hemangiomas (HP:0005306) | 1.68363692 |
| 184 | Palmoplantar hyperkeratosis (HP:0000972) | 1.68345594 |
| 185 | Cerebral ischemia (HP:0002637) | 1.66546800 |
| 186 | Conjunctival hamartoma (HP:0100780) | 1.66182245 |
| 187 | Skin nodule (HP:0200036) | 1.64966613 |
| 188 | Disinhibition (HP:0000734) | 1.64602559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.79304012 |
| 2 | FRK | 3.74800624 |
| 3 | MAP3K14 | 3.62457727 |
| 4 | ZAK | 3.15535803 |
| 5 | EIF2AK3 | 3.15274030 |
| 6 | SCYL2 | 3.03402026 |
| 7 | MST4 | 2.80076986 |
| 8 | TTK | 2.67927794 |
| 9 | MKNK2 | 2.60957318 |
| 10 | SRPK1 | 2.57467288 |
| 11 | AKT3 | 2.56119493 |
| 12 | BRSK2 | 2.50031255 |
| 13 | ERBB3 | 2.49578669 |
| 14 | MKNK1 | 2.46739381 |
| 15 | CDC7 | 2.34381853 |
| 16 | NEK9 | 2.34040972 |
| 17 | MAP3K10 | 2.26169213 |
| 18 | BRD4 | 2.24354211 |
| 19 | JAK1 | 2.16468594 |
| 20 | TSSK6 | 2.14969564 |
| 21 | JAK3 | 2.07025236 |
| 22 | FGFR3 | 1.99539004 |
| 23 | SGK2 | 1.98299520 |
| 24 | EIF2AK1 | 1.97986504 |
| 25 | NUAK1 | 1.94395437 |
| 26 | BUB1 | 1.81604062 |
| 27 | PIK3CA | 1.78087006 |
| 28 | BCR | 1.77848820 |
| 29 | TIE1 | 1.77501978 |
| 30 | EEF2K | 1.75338256 |
| 31 | LATS1 | 1.73139374 |
| 32 | SGK3 | 1.65321802 |
| 33 | CHUK | 1.64482517 |
| 34 | PLK4 | 1.59381176 |
| 35 | TYK2 | 1.58809734 |
| 36 | BMPR2 | 1.58131998 |
| 37 | NLK | 1.56894683 |
| 38 | IKBKB | 1.50878621 |
| 39 | EPHA3 | 1.46268096 |
| 40 | NEK1 | 1.45125219 |
| 41 | TRPM7 | 1.41311305 |
| 42 | ACVR1B | 1.40218853 |
| 43 | TAF1 | 1.38794693 |
| 44 | JAK2 | 1.38184525 |
| 45 | WEE1 | 1.33264446 |
| 46 | FGFR2 | 1.29226671 |
| 47 | ERBB4 | 1.24829256 |
| 48 | FGFR4 | 1.22686785 |
| 49 | MYLK | 1.22601485 |
| 50 | RIPK1 | 1.22109583 |
| 51 | PTK6 | 1.21087500 |
| 52 | RPS6KB2 | 1.19219964 |
| 53 | OBSCN | 1.15675857 |
| 54 | PAK3 | 1.15392127 |
| 55 | SGK494 | 1.14432753 |
| 56 | SGK223 | 1.14432753 |
| 57 | TNIK | 1.14044141 |
| 58 | CDK12 | 1.10666679 |
| 59 | LATS2 | 1.09087524 |
| 60 | BMX | 1.07669228 |
| 61 | STK3 | 1.04750084 |
| 62 | STK24 | 1.04555388 |
| 63 | YES1 | 1.02347256 |
| 64 | EPHB2 | 1.02010194 |
| 65 | TGFBR1 | 1.01601630 |
| 66 | LIMK1 | 0.98150390 |
| 67 | CDK6 | 0.96306526 |
| 68 | SIK1 | 0.95003225 |
| 69 | TBK1 | 0.93381067 |
| 70 | MAP3K13 | 0.93125421 |
| 71 | BMPR1B | 0.91317610 |
| 72 | STK38L | 0.90288124 |
| 73 | VRK1 | 0.88943968 |
| 74 | EIF2AK2 | 0.88776956 |
| 75 | ATM | 0.87730016 |
| 76 | IKBKE | 0.86753240 |
| 77 | TRIM28 | 0.86679836 |
| 78 | PDGFRA | 0.86325730 |
| 79 | INSRR | 0.86168075 |
| 80 | WNK1 | 0.85316167 |
| 81 | TESK1 | 0.85197417 |
| 82 | ATR | 0.84226633 |
| 83 | PLK2 | 0.83733418 |
| 84 | CHEK2 | 0.83277073 |
| 85 | PKN2 | 0.81839128 |
| 86 | PLK1 | 0.78445881 |
| 87 | RPS6KA4 | 0.78432533 |
| 88 | PKN1 | 0.78279316 |
| 89 | PRKCQ | 0.76861389 |
| 90 | CDK4 | 0.76195541 |
| 91 | FGFR1 | 0.74390292 |
| 92 | KSR1 | 0.72112745 |
| 93 | CCNB1 | 0.72001816 |
| 94 | ALK | 0.70775849 |
| 95 | PRKCH | 0.70579259 |
| 96 | ROCK1 | 0.69148702 |
| 97 | AURKB | 0.68586264 |
| 98 | MAP3K12 | 0.67835282 |
| 99 | RAF1 | 0.66723278 |
| 100 | PIK3CG | 0.65569164 |
| 101 | STK4 | 0.65274513 |
| 102 | CLK1 | 0.63613188 |
| 103 | CHEK1 | 0.62866660 |
| 104 | STK39 | 0.61958942 |
| 105 | MAP3K4 | 0.60972497 |
| 106 | MET | 0.60557433 |
| 107 | DDR2 | 0.60336617 |
| 108 | PBK | 0.59945876 |
| 109 | RPS6KB1 | 0.56700087 |
| 110 | CSNK1A1L | 0.55002225 |
| 111 | MAP2K3 | 0.54457801 |
| 112 | IRAK4 | 0.54018803 |
| 113 | KSR2 | 0.53750014 |
| 114 | CDK7 | 0.52924303 |
| 115 | TRIB3 | 0.52460840 |
| 116 | MAP3K8 | 0.52312214 |
| 117 | MAP3K2 | 0.50949330 |
| 118 | TTN | 0.50306651 |
| 119 | PNCK | 0.48753970 |
| 120 | CSNK1E | 0.48631780 |
| 121 | PLK3 | 0.48486665 |
| 122 | PRKCE | 0.48190533 |
| 123 | BRAF | 0.47805039 |
| 124 | IGF1R | 0.46607454 |
| 125 | PTK2B | 0.45651238 |
| 126 | TEC | 0.45551872 |
| 127 | SGK1 | 0.45050249 |
| 128 | PDGFRB | 0.43460184 |
| 129 | MAPK11 | 0.43227134 |
| 130 | CDK1 | 0.42992618 |
| 131 | PRKAA2 | 0.41496653 |
| 132 | CDC42BPA | 0.40932945 |
| 133 | DMPK | 0.40861849 |
| 134 | CDK2 | 0.40726419 |
| 135 | MAP3K3 | 0.39786598 |
| 136 | RET | 0.39292759 |
| 137 | NEK2 | 0.38367696 |
| 138 | MAPKAPK5 | 0.37962164 |
| 139 | GSK3A | 0.37567238 |
| 140 | NEK6 | 0.36552891 |
| 141 | PIM1 | 0.35775269 |
| 142 | INSR | 0.35734728 |
| 143 | MELK | 0.35715650 |
| 144 | PRKCZ | 0.33198557 |
| 145 | PDK2 | 0.32876455 |
| 146 | IRAK1 | 0.32491963 |
| 147 | FLT3 | 0.32394070 |
| 148 | MAP3K5 | 0.31932154 |
| 149 | ZAP70 | 0.31776345 |
| 150 | MAPKAPK2 | 0.31469433 |
| 151 | AKT2 | 0.31120652 |
| 152 | MAP2K1 | 0.30903483 |
| 153 | PRKAA1 | 0.30821819 |
| 154 | CSNK2A2 | 0.29993146 |
| 155 | PRKACG | 0.29778059 |
| 156 | TGFBR2 | 0.29586612 |
| 157 | FER | 0.29375179 |
| 158 | ABL2 | 0.29321419 |
| 159 | PRKDC | 0.29020657 |
| 160 | AKT1 | 0.27820601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 4.47939684 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.06220767 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.77901481 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.52306985 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17414117 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.02815431 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.97529294 |
| 8 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.93586629 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.70939943 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.55611831 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.49696539 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46736570 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43504448 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43481313 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.11869758 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09357139 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.08926408 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08583917 |
| 19 | Asthma_Homo sapiens_hsa05310 | 2.06244399 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.02762160 |
| 21 | Thyroid cancer_Homo sapiens_hsa05216 | 1.99847089 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96791567 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89965188 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.80218556 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.79298575 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.78883984 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.71350532 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.66919318 |
| 29 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63653822 |
| 30 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.61215733 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.60410863 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54929056 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50053752 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45287305 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.42733762 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.38793945 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37308539 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.37175992 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.31879752 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.31221585 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.30416820 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27655095 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22158912 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22004241 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21152809 |
| 46 | Alcoholism_Homo sapiens_hsa05034 | 1.19551325 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19333022 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15235232 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13769675 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13270400 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13204462 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13081716 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12949808 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.12412259 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 1.12313909 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12310479 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09944116 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.09312750 |
| 59 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.09160073 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07852131 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06124883 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04850098 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02870148 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02378136 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01181222 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01100578 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00551126 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00043187 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.99916829 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99873420 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99309744 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99060760 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93358118 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92094082 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92005314 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91057478 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90356546 |
| 78 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90341744 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89838261 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89495144 |
| 81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89345454 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88453441 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.86447102 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85682944 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85270198 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.85163091 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83737430 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.83564300 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82115102 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81583276 |
| 91 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80025590 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79779816 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79449542 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75561171 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75130067 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74693543 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.73004169 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71421981 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71257705 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70979926 |
| 101 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70922469 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.70705939 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.67157549 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67077134 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65656187 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65257195 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65185383 |
| 108 | Adherens junction_Homo sapiens_hsa04520 | 0.64800990 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.63333595 |
| 110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.61791713 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60854519 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60773006 |
| 113 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59613992 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.58784448 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58719499 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58551212 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57724889 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56996047 |
| 119 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56899544 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56854784 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.56416530 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55580063 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.54730509 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.54726942 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53977684 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.53609483 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53586259 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53318639 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.52542551 |
| 130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51680570 |
| 131 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51338117 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49959944 |
| 133 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49916694 |
| 134 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48841302 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.48764773 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.47213314 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47104791 |
| 138 | Base excision repair_Homo sapiens_hsa03410 | 0.46650750 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46423028 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.46374686 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.46295720 |
| 142 | ABC transporters_Homo sapiens_hsa02010 | 0.45597175 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44405657 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44341734 |
| 145 | RNA polymerase_Homo sapiens_hsa03020 | 0.44246452 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | 0.43842805 |
| 147 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42834077 |
| 148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40470166 |
| 149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40435484 |
| 150 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40155230 |
| 151 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38812188 |
| 152 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38532492 |
| 153 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38508894 |
| 154 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37501711 |
| 155 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.37205439 |
| 156 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36874663 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.35895495 |
| 158 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35598868 |
| 159 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34902738 |
| 160 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34101033 |
| 161 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33625823 |
| 162 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33521743 |
| 163 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32786964 |
| 164 | Hepatitis B_Homo sapiens_hsa05161 | 0.32448055 |
| 165 | Purine metabolism_Homo sapiens_hsa00230 | 0.31784305 |
| 166 | Melanoma_Homo sapiens_hsa05218 | 0.31154618 |
| 167 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29825377 |
| 168 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29155598 |
| 169 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28998685 |

